Shenzhen Fu Mi Health Technology Co., Ltd. is a leading Chinese autism spectrum disorder (ASD) child service platform. Founded in 2014 by Jiang Yingshuang, the company offers a comprehensive range of services including rehabilitation, inclusive education support, parent training, online courses, and information dissemination. In August 2018, the company established an independent R&D team in Beijing, collaborating with top experts and scholars domestically and internationally to develop the RICE intervention and rehabilitation system, the first of its kind in China with independent intellectual property rights.
Currently, Da Mi and Xiao Mi operates 9 children's growth centers and 3 inclusive kindergartens in Shenzhen, Shanghai, Guangzhou, Beijing, and Zhengzhou, serving over 3000 ASD and developmentally delayed children. Furthermore, the company has accumulated data on over 8 million pathologies and sociological backgrounds of Chinese autistic children, as well as trained more than 600 special education professionals independently. It has also secured investments, with the latest being a $42.00M Series D investment on 28 July 2022 led by ABC Impact and Grand Flight Investment.
Da Mi and Xiao Mi's reach extends beyond physical centers, as it has also become a prominent media and community platform in the field of ASD and pervasive developmental disorders, with significant followings on various social media platforms. Over the past five years, it has garnered attention from ASD parents, special education and rehabilitation teachers, ASD-related doctors, and experts domestically and internationally, positioning itself as a crucial information hub for connecting various stakeholders in the field.
